GOCOQ GoHealth (GOCOQ) Insider Trading, Ownership & Congress Trades
Insurance · Insurance agents, brokers & service · CIK 0001808220
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
1
13F, latest reported quarter
GoHealth insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for GoHealth, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
no insider purchases or sales on record
0 transactions on record
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
1 fund bought in last quarter
the lowest in Insurance
Revenue
-54.7% year over year
below 98% of Insurance
Margin
-71.1% net margin
below 93% of Insurance
Buybacks
no share repurchases reported
Short interest
no short interest reported
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch GOCOQ
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
Who owns GOCOQ: institutional holders (13F)
13F holdings, latest reported quarter
66,170 sh
$25.5K
19,175 sh
$7.4K
3,679 sh
$1.4K
66 sh
$25
$2
Congress trades in GOCOQ
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
GOCOQ planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
GOCOQ mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
VANGUARD RUSSELL 2000 VALUE INDEX FUND
$4.8K position · as of 2026-05-31
0.0%
VANGUARD RUSSELL 2000 INDEX FUND
$30.8K position · as of 2026-05-31
0.0%
ProShares Russell 2000 High Income ETF
$285 position · as of 2026-05-31
0.0%
Fidelity Extended Market Index Fund
$52.4K position · as of 2026-05-31
0.0%
Small Cap Index Fund
$1.3K position · as of 2026-05-31
0.0%
ProShares Ultra Russell2000
$222 position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 1 funds added last quarter. Each figure is a federal filing, dated the day it went public.
GOCOQ financials
Revenue growth
-54.7%
XBRL, annual
Net margin
-71.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$152.8M
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM GOCOQ
| FY Dec 2025 | $361.8M |
| FY Dec 2024 | $798.9M |
| FY Dec 2023 | $734.7M |
| FY Dec 2022 | $631.7M |
| FY Dec 2021 | $1.1B |
| Mar 2026 | $11.9M |
| Dec 2025 | $12.6M |
| Sep 2025 | $34.2M |
| Jun 2025 | $94.0M |
| Mar 2025 | $221.0M |
| Dec 2024 | $389.1M |
| Sep 2024 | $118.3M |
| Jun 2024 | $105.9M |
At each fiscal year end
Single quarter
Net margin, TTM
-189.7%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM GOCOQ
| FY Dec 2025 | -71.1% |
| FY Dec 2024 | -0.4% |
| FY Dec 2023 | -8.6% |
| FY Dec 2022 | -23.5% |
| FY Dec 2021 | -17.8% |
| Mar 2026 | -312.0% |
| Dec 2025 | -257.9% |
| Sep 2025 | -485.1% |
| Jun 2025 | -57.7% |
| Mar 2025 | -2.0% |
| Dec 2024 | +6.6% |
| Sep 2024 | +5.7% |
| Jun 2024 | -24.6% |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$107.8M
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM GOCOQ
| FY Dec 2025 | -$130.2M |
| FY Dec 2024 | -$35.3M |
| FY Dec 2023 | $95.4M |
| FY Dec 2022 | $47.4M |
| FY Dec 2021 | -$318.8M |
| Mar 2026 | $7.0M |
| Dec 2025 | -$39.1M |
| Sep 2025 | -$35.0M |
| Jun 2025 | -$40.6M |
| Mar 2025 | -$15.5M |
| Dec 2024 | $12.4M |
| Sep 2024 | -$16.5M |
| Jun 2024 | -$39.2M |
At each fiscal year end
Single quarter
Debt to equity
306.49x
long-term 2026-03-31 plus current 2026-03-31; equity 2026-03-31
Debt to equity GOCOQ
| FY Dec 2025 | 16.81x |
| FY Dec 2024 | 2.02x |
| FY Dec 2023 | 2.15x |
| FY Dec 2022 | 1.90x |
| FY Dec 2021 | 1.90x |
| Mar 2026 | 306.49x |
| Dec 2025 | 16.81x |
| Sep 2025 | 8.54x |
| Jun 2025 | 2.92x |
| Mar 2025 | 2.01x |
| Dec 2024 | 2.02x |
| Sep 2024 | 2.27x |
| Jun 2024 | 2.24x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.16x
TTM operating cash flow over long-term 2026-03-31 plus current 2026-03-31
Cash flow to debt GOCOQ
| FY Dec 2025 | -0.19x |
| FY Dec 2024 | -0.04x |
| FY Dec 2023 | 0.22x |
| FY Dec 2022 | 0.12x |
| FY Dec 2021 | -0.45x |
| Mar 2026 | -0.16x |
| Dec 2025 | -0.19x |
| Sep 2025 | -0.12x |
| Jun 2025 | -0.09x |
| Mar 2025 | -0.10x |
| Dec 2024 | -0.04x |
| Sep 2024 | 0.07x |
| Jun 2024 | 0.12x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-237.9%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity GOCOQ
| FY Dec 2025 | -183.9% |
| FY Dec 2024 | -1.2% |
| FY Dec 2023 | -25.3% |
| FY Dec 2022 | -47.8% |
| FY Dec 2021 | -51.6% |
| Mar 2026 | -237.9% |
| Dec 2025 | -183.9% |
| Sep 2025 | -142.1% |
| Jun 2025 | -13.4% |
| Mar 2025 | +0.8% |
| Dec 2024 | -1.2% |
| Sep 2024 | -13.5% |
| Jun 2024 | -26.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-25.2%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets GOCOQ
| FY Dec 2025 | -20.8% |
| FY Dec 2024 | -0.2% |
| FY Dec 2023 | -4.0% |
| FY Dec 2022 | -8.0% |
| FY Dec 2021 | -9.1% |
| Mar 2026 | -25.2% |
| Dec 2025 | -20.8% |
| Sep 2025 | -16.8% |
| Jun 2025 | -2.1% |
| Mar 2025 | +0.1% |
| Dec 2024 | -0.2% |
| Sep 2024 | -2.1% |
| Jun 2024 | -4.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital GOCOQ
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | +0.3% |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-46.9%
operating income (EBIT proxy) over average of 2025-03-31 and 2026-03-31 minus current liabilities
Return on capital employed GOCOQ
| FY Dec 2025 | -41.4% |
| FY Dec 2024 | -0.6% |
| FY Dec 2023 | -6.5% |
| FY Dec 2022 | -19.6% |
| FY Dec 2021 | -25.5% |
| Mar 2026 | -46.9% |
| Dec 2025 | -41.4% |
| Sep 2025 | -31.4% |
| Jun 2025 | -5.1% |
| Mar 2025 | +0.3% |
| Dec 2024 | -0.6% |
| Sep 2024 | -6.3% |
| Jun 2024 | -5.9% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
no close on file at or before the as-of date
P/E, trailing GOCOQ
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no close on file at or before the as-of date
Enterprise value GOCOQ
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no close on file at or before the as-of date
FCF yield GOCOQ
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
no close on file at or before the as-of date
PEG, trailing GOCOQ
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $361.8M | $798.9M | $734.7M | $631.7M |
| Operating income | -$412.9M | -$7.0M | -$81.7M | -$318.7M |
| Net income | -$257.1M | -$2.9M | -$63.3M | -$148.7M |
| EPS (diluted) | -20.17 | -0.66 | -7.19 | -17.72 |
| Operating cash flow | -$121.9M | -$21.6M | $109.1M | $60.9M |
| Cash | $32.9M | $40.9M | $90.8M | $16.5M |
| Long-term debt | $636.7M | $447.9M | $422.7M | $504.8M |
SEC XBRL, fiscal years, as known on 2026-10-28
GOCOQ Stock Sonar score 5/7 axes
Find similar shapesCompareGOCOQ ranks highest on risk and compliance (42nd percentile) and profitability (8th), and lowest on institutional and government (1st), among Insurance peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
